After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

Oura announced the rollout of two new features, Meals and Glucose, to give users a clearer view of how daily behaviors affect ...

DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins. Check out why I am lowering my rating on DXCM from buy to hold.

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...

DXCM's first-quarter 2025 earnings decline despite increasing sales. Its performance in 2025 is expected to be fueled by ...

Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with ...

I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at ...

Shares of DexCom jumped over 15% to pace the S&P 500's advancers Friday, a day after the maker of glucose monitoring devices ...

DexCom Inc. closed 38.36% below its 52-week high of $132.26, which the company reached on May 17th.

DexCom Inc. closed 39.31% below its 52-week high of $132.26, which the company reached on May 17th.